<DOC>
	<DOCNO>NCT01856348</DOCNO>
	<brief_summary>The study conduct assess effect vitamin D3 supplementation activity two intestinal transporter pharmacokinetics transporter substrates folic acid fexofenadine . - Trial medicinal product</brief_summary>
	<brief_title>Vitamin D3 , Folic Acid Fexofenadine Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Dihydroxycholecalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<mesh_term>Fexofenadine</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Inclusion criterion : 1. male female 2. age 18 65 year study entry 3. sign inform consent form 4 . Body Mass Index &gt; 18 &lt; 30 kg/m2 5 . Participants must diseases ( assessed screen examination ) 6 . Participants must take concomitant medication except oral contraceptive females 7 . Normal blood count Exclusion criterion : 1 . Subjects confirm suspected hypersensitivity towards study medication 2 . Contemporaneous participation study 3 . Females : pregnancy 4 . Females : breastfeed 5 . Clinically significant abnormal laboratory finding 6 . Known suspected present past malignancy kind 7 . Known suspect active infection , serious infection precede 3 month 8 . Positive hepatitis B , hepatitis C / HIV 1/2 serology 9 . Subjects know suspect comply study regulation 10 . Subjects employ participate department University Hospital ZÃ¼rich . 11 . Known suspected present past disease may interfere study 12. smoker 13. alcohol drug abuse</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>